Joseph D Fisher

Title: Joseph D. Fisher: Innovator in Hematology

Introduction

Joseph D. Fisher is a notable inventor based in Chicago Heights, IL (US). He has made significant contributions to the field of hematology, particularly in the development of methods for producing safe blood components. With a total of 3 patents to his name, Fisher's work has had a meaningful impact on medical practices.

Latest Patents

One of Fisher's latest patents is for the "Preparation of Pasteurized Human Plasminogen." This invention relates to a method for producing a plasminogen preparation that has been pasteurized to ensure it is safe for injection, particularly in terms of hepatitis risk. The method involves adding a protective agent, such as methyl lysine ester or ethyl lysine ester, to an aqueous solution of plasminogen. This agent attaches to the plasminogen, forming a modified version that is then subjected to heat treatment. Another significant patent is for the "Heat Defibrinogenation of AHF Preparation." This process involves extracting antihemophilic factor (AHF) from cryoprecipitate by selectively denaturing fibrinogen through rapid temperature changes, allowing for the separation of AHF-rich supernatant.

Career Highlights

Joseph D. Fisher is currently associated with Armour Pharmaceutical Company, where he continues to innovate in the field of blood component preparation. His work has been instrumental in enhancing the safety and efficacy of blood products used in medical treatments.

Collaborations

Fisher has collaborated with notable colleagues, including Willie M. Curry and Michael E. Hrinda. Their combined expertise has contributed to advancements in the field of hematology and the development of safer medical products.

Conclusion

Joseph D. Fisher's contributions to the field of hematology through his innovative patents demonstrate his commitment to improving medical practices. His work continues to influence the safety and effectiveness of blood component therapies.